These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3895457)

  • 1. [A diuretic, oxodolin, in the treatment of hypertension].
    Liusov VA; Kharchenko VI; Istomina IA; Ivanushkina ZN; Evsikov EM
    Sov Med; 1985; (3):3-9. PubMed ID: 3895457
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hemodynamic mechanisms of the hypotensive effect of hypothiazide and oxodolin].
    Levinzon AM; Glezer GA
    Klin Med (Mosk); 1987 Apr; 65(4):36-40. PubMed ID: 3599853
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative study of the combination of chlorthalidone with verapamil and metoprolol in arterial hypertension: evaluation by cycloergometrics].
    Candau LA; Pereira LS; Scherr C
    Arq Bras Cardiol; 1981 Aug; 37(2):133-8. PubMed ID: 6753801
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical trials with clonidine-chlorthalidone, a combined preparation in the treatment of hypertensive diseases].
    Dejaco RM; Hartl O
    Wien Med Wochenschr; 1973 Feb; 123(7):96-9. PubMed ID: 4631628
    [No Abstract]   [Full Text] [Related]  

  • 5. Double-blind crossover study of fenquizone compared to chlorthalidone in essential hypertension.
    Angelino PF; Alvino-Demartino A; Mappa R; Donati C
    Int J Clin Pharmacol Ther Toxicol; 1985 Sep; 23(9):501-5. PubMed ID: 3902676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Multicenter study with a fixed combination of oxprenolol/chlorthalidone in essential arterial hypertension].
    Albanesi Filho FM; Benchimol AB
    Arq Bras Cardiol; 1980 May; 34(5):409-14. PubMed ID: 7006573
    [No Abstract]   [Full Text] [Related]  

  • 7. [Advantages of a fixed association of oxprenolol-chlorthalidone, as opposed to chlorthalidone alone, in the treatment of chronic essential arterial hypertension].
    Baronchelli A; Agosta R; Verdecchia P; Bichisao E
    Clin Ter; 1981 Apr; 97(1):63-9. PubMed ID: 7026137
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of the antihypertensive efficacy of acebutolol, chlorthalidone and the combination of acebutolol and chlorthalidone in the treatment of mild and moderate primary arterial hypertension].
    Del Nero Júnior E; Lima EV; Savioli RM; de Rezende MC
    Arq Bras Cardiol; 1983 May; 40(5):357-61. PubMed ID: 6360100
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of hypertension with the beta-receptor-antagonist pindolol (Viskèn). A comparison with chlorthalidone (Hygroton)].
    Schaffalitzky de Muckadel ; Gyntelberg F
    Ugeskr Laeger; 1973 May; 135(20):971-4. PubMed ID: 4585570
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical study on the hypotensive action of a chlorthalidone-reserpine association.
    Strata A; Salvatore V
    Panminerva Med; 1966 Apr; 8(4):113-20. PubMed ID: 5329329
    [No Abstract]   [Full Text] [Related]  

  • 11. [Atenolol-chlorthalidone combination vs placebo: controlled clinical trial in patients with medium-mild arterial hypertension].
    Campana C; Ferrario M; Tondi C; Montemartini C
    Minerva Cardioangiol; 1985 Oct; 33(10):643-7. PubMed ID: 3908972
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the anti-hypertensive action of the chlorthalidone-reserpine combination. Clinical contribution].
    Avanzi G
    Minerva Med; 1965 Dec; 56(99):4358-65. PubMed ID: 5323493
    [No Abstract]   [Full Text] [Related]  

  • 13. [Report on the clinical evaluation of the antihypertensive effects of Urandil A VUFB].
    Suchová H; Mayer O; Cepelák V
    Vnitr Lek; 1984 Feb; 30(2):169-74. PubMed ID: 6372237
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of oxprenolol plus chlorthalidone in fixed combination against chlorthalidone alone in mild to moderate essential hypertension; a clinical trial.
    Gruppillo P; Tomasi AM; Masoni A; Finzi C
    G Ital Cardiol; 1980; 10(4):476-9. PubMed ID: 7002694
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of refractory hypertension with a fixed oxprenolol/chlorthalidone/hydralazine combination. Results of an open multicenter trial].
    Krönig B; Wendt G
    Med Welt; 1983 Sep; 34(35):941-4. PubMed ID: 6355745
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prolonged treatment of arterial hypertension of arteriosclerotic origin with a combination of chlorthalidone and reserpine].
    Grimaldi MG
    Clin Ter; 1967 Mar; 40(6):533-63. PubMed ID: 5601194
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of arterial hypertensive disease with diuretics. IV. Effects of long-term high sodium intake on the response to chlorthalidone.
    Johnston LC; Grieble HG; Schoenberger JA; Gantt CL
    Am J Med Sci; 1965 Dec; 250(6):680-7. PubMed ID: 5321241
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antihypertensive effects of clonidine and of the clonidine-chlorthalidone combination].
    D'Amelio G; Dalla Volta S; De Longhi B; Razzolini R
    Minerva Med; 1974 May; 65(41):2342-9. PubMed ID: 4602117
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of arterial hypertension in patients refractory to therapeutic diuretics. Comparative study of verapamil and propranolol].
    Wajngarten M; Solorzano J; Godoy M; Barretto AC; Pileggi F
    Arq Bras Cardiol; 1982 Jun; 38(6):499-502. PubMed ID: 6762870
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of antihypertensive therapy on oxygen consumption of the myocardium. I. Hydrochlorothiazide and chlorthalidone].
    Sau F; Raffo M; Seguro C; Pisano MR; Pirisi R; Cherchi A
    Boll Soc Ital Cardiol; 1981; 26(12):1941-51. PubMed ID: 7185366
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.